• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Markets Equities Stock Market

Global stocks surge higher as AstraZeneca resumes COVID-19 vaccine trial

Olumide AdesinabyOlumide Adesina
3 years ago
in Stock Market
Best performing global financial assets in the last 7 days, Many Nigerians are trooping into foreign stocks, Foreign Investors Ignore Nigerian Stocks rally, Global stocks become blockbusters, optimism rises for COVID-19 cure
Share on FacebookShare on TwitterShare on Linkedin

Asian stocks and U.S futures rallied higher on Monday morning. The upsurge is a result of renewed hopes for a COVID-19 vaccine, after leading drug maker AstraZeneca resumed its phase-3 trials.

However, investors still remain wary, as mark indicators showed institutional investors adjusting their portfolios ahead of a big week of central bank meetings in the United States, Japan, and the United Kingdom.

At the time of this report, MSCI’s broadest index of Asia-Pacific shares outside Japan gained 0.7%, poised for its second straight trading session of gains.

READ: Ethiopia to begin manufacture and export of COVID-19 test kits

Australian shares also rallied higher by 0.6%, while Japan’s Nikkei 225 Index gained 0.7%. Chinese shares started firm with the blue-chip index (CSI300) rising 0.6%.

U.S. stock futures, the S&P 500 futures, gained more than 1%, as global traders increased their long bets on the prevailing macro, after AstraZeneca disclosed over the weekend, that it had resumed the clinical trials of its COVID-19 vaccine, one of the most advanced and credible developments, after getting the green light from health regulators

A vaccine has long been awaited to help pull the world out of a COVID-19 induced lockdown.

READ: Russia’s COVID-19 vaccine shows no negative side effects

Stephen Innes, Chief Global Market Strategist at AxiCorp, in a note to Nairametrics, spoke on why it might be too early for investors to begin partying, as prevailing macros show that uncertainty remains.

“Investors face many uncertainties moving into the Northern Hemisphere Autumn, most notably on the US elections and the global pandemic path.

READ: China publicly presents its COVID-19 vaccines, 2 doses to cost below $146

“Unquestionably the virus story is the dominant macro event, especially for equities, and is more likely to be dominated by optimism surrounding a vaccine. Investors will be keeping their eyes on the vaccine price.”

Related

Tags: AstraZenecaCovid-19Covid-19 vaccineMSCINikkei 225 indexS&P 500 futureStephen Innes

Leave a Reply Cancel reply

hfm
UBA
Mega Millions
Mega Millions
fidelity banner
HFM
webinar







NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Patricia suffers massive losses in crypto assets after security breach
  • From the Garden City to New York; How Mr Eazi made it
  • Buhari says Nigeria’s stock of infrastructure to GDP doubled to over 40%

Follow us on social media:

Recent News

Patricia

Patricia suffers massive losses in crypto assets after security breach

May 28, 2023
From the Garden City to New York; How Mr Eazi made it

From the Garden City to New York; How Mr Eazi made it

May 28, 2023
  • Download Nairametrics iOS App
  • Download Nairametrics Android App
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Login
  • Sign Up
  • Cart

© 2023 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In